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Concurrent Colorectal Malignancy & Aortic Aneurysm 545Literature review identified 269 such cases; of these 101 were treated by combined surgery. In
staged surgery, there were nine interval aneurysmal ruptures and one aortic graft infection.
Conclusions: In our experience, staged management can be undertaken, without interval
aneurysmal rupture. EVAR has an evolving role in preventing delay in CRC management, in
high-risk patients, and during combined intervention.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.The synchronous presentation of colorectal carcinoma
(CRC) and abdominal aortic aneurysm (AAA) is
uncommon.1,2 The true incidence is difficult to accurately
ascertain, but has been reported as being between 0.49%
and 2.1%.1,2 It is likely this incidence will increase in an
ageing population.3 Concurrence may be attributable to
similar patient demographics (increasing age) and common
risk factors (smoking).4 Alternative postulated mechanisms
include immunological responses and disturbances in the
relationship of epithelia to the connective tissue matrix.5
Presentation with this dual pathology represents
a significant surgical challenge in the absence of a clear
consensus from the surgical literature on the optimal
management of these patients.6e8 When surgery is indi-
cated, a decision needs to be made on whether a combined
or staged approach should be adopted. Advocates of
combined surgery report excellent result with minimal
delay in the treatment of either pathology, minimising the
risk of disease progression or rupture.4,9e13 There is pre-
vailing concern among critics with respect to this policy of
the risk of graft infection and prolonged operative proce-
dure time and trauma.14,15 A policy of staged procedures
partially alleviates these concerns, but a decision on pri-
oritising either pathology makes it a less straightforward
option.
Initial resection of CRC followed by staged aneurysm
repair is undermined by the potential risk of aneurysmal
rupture after the cancer operation.2,3,6,16 This is supported
by evidence of collagen lysis enhanced by surgical dissec-
tion, postoperative nutritional depletion and inflammatory
response to surgery.1,2,6,7,17,18 Conversely, aneurysm repair
followed by CRC resection delays cancer surgery and
adjuvant therapy, potentially facilitating tumour progres-
sion.6 There is also concern regarding tumour obstruction
and perforation19 and aortic graft infection with this order
of staged approach.3
Endovascular aortic repair (EVAR) is a promising alter-
native to open repair. Evidence from numerous multicentre
trials demonstrate decreased perioperative morbidity and
mortality, shorter hospital stays and reduced need for
general anaesthesia when compared with open repair.20e22
Does EVAR introduce another variable into this already
complex therapeutic paradigm, or does it negate some of
the issues related to the management of concurrent CRC
and AAA, thereby simplifying treatment planning?
This study aims to examine the recent experience at two
centres in treating patients presenting with concurrent CRC
and AAA, review the published literature on this subject
and explore the role of EVAR in this context.Materials and Methods
Consecutive patients with concurrent CRC and non-
ruptured aorto-iliac aneurysmal disease were identified
from the databases of prospective colorectal cancer from
two units between 2001 and 2006. The patient demo-
graphics, aneurysm size and classification and site and
stage of primary CRC were recorded. The planned and
actual course of management, including the type of colonic
resection and aneurysm repair, as well as outcomes, was
identified.
Medline, Embase, Ovid, Cochrane Database and Google
Scholar searches were performed on all clinical studies
published up to and including 1 March 2008 investigating
the management of co-existing CRC and aortic-iliac aneu-
rysmal disease. Publications relating to humans in all
languages were used. The search was expanded using the
‘Related Articles’ function from each relevant publication
identified. Where identifiable in published series, patient
demographics, aneurysm and CRC details, operative
strategy, mortality and morbidity, in particular, interval
AAA rupture and graft sepsis, were recorded.Results
Patient Demographics
Twenty-four patients with median age of 74 years (range:
60e94 years) were presented over this 5-year period; of
these, 83% were male. Five cases were tertiary referrals
from outside centres. Median follow-up was 16.5 months
(range: 0.5e176 months) (Table 1).AAA and CRC Characteristics
All instances of CRC and AAA were diagnosed preoperatively
and no new diagnoses were made at operation. Twelve of
the 24 cases of AAA were incidental findings during inves-
tigations for CRC. In three patients, CRC was diagnosed on
radiological assessment of a known aneurysm.
The AAA types were infrarenal (nZ 14, 58%), juxtarenal
(nZ 5, 21%), suprarenal (nZ 3, 13%) and thoraco-abdom-
inal (nZ 2, 8%). The median AAA size was 6.0 cm (range:
3.5e8.5 cm). The CRC stages diagnosed were Duke’s A
(nZ 2, 8%), Duke’s B (nZ 10, 42%), Duke’s C (nZ 9, 37.5%)
and Duke’s D (nZ 3, 12.5%). Left-sided CRC constituted 17
of the cases, while six were right sided and one CRC was
located within the transverse colon.
Table 1 Summary of details and care of patients with concurrent colorectal cancer and aorto-iliac aneurysmal disease
Patient AAA CRC Intervention(s) Length
of stay
(days)
Adjuvant
chemotherapy
þ radiotherapy
Complications Time
Gender Age
(years)
Type Size
(cm)
Site Stage
(Duke)
Post
-CRC
surgery
Post
AAA repair
Interval
(months)
Period of
follow-up
(months)
Death
(months)
Male 72 SR 8.5 Distal
Descending
B Combined Open
AAA then CRC
11 12 e Intra-operative
bleed delayed
CRC resection
2 6 e
Male 83 IR 7.0 Descending A Staged EVAR
then CRC
7 49 e Post-EVAR: distal
type I EL re-explored
and complicatedby
postprocedural MI,
AF, ARF requiring
CVVHDF, and
a slow ventilatory
wean; 14d ICU stay
2 17 22.5
(unrelated)
Male 79 IR 8.0 Sigmoid B Staged EVAR
then CRC
9 6 e e 1.5 16 e
Male 86 JR 6.8 Ascending C Staged CRC
then EVAR
5 6 e e 25 60 e
Male 75 IR 6.0 Transverse C Staged CRC
then EVAR
5 6 Palliative
chemo at
1 year
EVAR stent-graft
occlusion at 6 wks;
left axillo-fem and
fem-fem cross-over
5.5 12 21 (CRC
recurrence)
Male 65 IR 6.9 Ascending C Staged CRC
then EVAR
57 7 Adjuvant
chemo between
interventions
Post right hemi: MI
and cardiac arrest;
anastomotic leak with
laparotomy.Post EVAR:
type II EL managed
conservatively; resol-
ved at 12 m.
13 176 e
Male 68 IR 7.0 Ascending B Staged CRC
then EVAR
13 7 Adjuvant
chemo between
interventions
Post EVAR: bilateral
groin haematomas;
further endovascular
intervention at 1wk;
left CIA occlusion;
fem-fem cross-over
2 72 e
Male 70 IR 6.2 Rectum C Staged CRC
then EVAR
16 8 Adjuvant
chemorad
between
interventions
Post ARþ rad: radia
tion proctitis; second
laparotomy and
proctectomy
22 72 e
Male 60 IR 5.5 Hepatic
Flexure
D Staged CRC
then EVAR
13 7 Adjuvant
chemo between
interventions
Post EVAR: type
II EL managed conse-
rvatively; resolved
at 3 m
8 48 e
Male 72 IR 6.5 Sigmoid C Staged CRC
then EVAR
18 4 Adjuvant chemo
post EVAR
Post EVAR: type I EL
at 1wk; aortic
cuff applied
2.5 6 e
Male 73 JR 6.0 Rectum A Staged CRC
then Open AAA
39 13 e AF/flutter requiring
DCCV
15 57.5 e
Male 73 JR 5.8 Sigmoid B Staged CRC
then Open AAA
5 7 e e 8 28 e
Male 73 JR 5.6 Distal
Sigmoid
B Staged CRC
then Open AAA
13 14 e e 5 44 e
Male 75 IR 4.0 Rectum C CRC Only 38 e e Colo-vesical fistula
managed conser-
vatively
e 72 74.5
(unrelated)
Male 85 IR 7.5 Mid
Sigmoid
B CRC Only 63 e e Post-CRC: wound
infection with VAC
dressing
e 4.5 6 (unrelated)
Male 83 IR 5.8 Caecum B CRC Only 42 e e e e 18 e
Male 69 JR 5.2 Rectum B CRC Only 4 e Neoadjuvant
rad
Post ARþ rad: acute
gastric dilatation and
gastric necrosis; CVA;
limb embolus
e 4.5 6 (in-hospital)
Male 81 IR 6.6 Hepatic
Flexure
C CRC Only 10 e Palliative chemo e e 12 16 (CRC
recurrence)
Female 85 TA 5.5 Splenic
Flexure
B CRC Only 13 e e e e 3 e
Male 87 IR 4.3 Rectum C CRC Only 6 e Death prior to
planned
palliative
chemo
e e 28 36 (CRC
recurrence)
Female 73 SR 5.8 Rectum C Palliative e e Palliative
chemoradþ de-
functioning
e e 2.5 e (palliative)
Male 90 IR 3.5 Rectum B Palliative e e e e e 16 16 (palliative)
Female 94 SR 8.5 Recto-
Sigmoid
D Palliative e e e e e 2.5 2.5
(palliative)
Female 73 TA 6.0 Sigmoid D Palliative e e Palliative
chemo
e e 0.5 6
(palliative)
There was no incidence of graft infection or aneurysm rupture.
AAA abdominal aortic aneurysm; AF atrial fibrillation; AR anterior resection; ARF acute renal failure; AVR aortic valve replacement; CABG coronary artery bypass grafting; chemo chemotherapy;
CIA common iliac artery; CRC colorectal cancer; CT computed tomography; CVA cerebrovascular accident; CVVHDF continuous veno-venous haemodiafiltration; d day; DCCV direct current
cardioversion; EL endoleak; EVAR endovascular aortic repair; fem-femoro/femoral; hemi hemicolectomy; ICU intensive care unit; IR infrarenal; JR juxtarenal; mets metastases; m months; MI
myocardial infarction; NSTEMI non-ST-elevation myocardial infarction; rad radiotherapy; SR suprarenal; TA thoraco-abdominal; VAC vacuum-assisted closure; wks weeks.
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Decisions regarding operation and the sequence of inter-
ventions were made between colorectal and vascular
multidisciplinary teams (MDTs). It was a policy to consider
EVAR in all patients in whom endovascular repair was
technically feasible.
Intervention for both malignancy and aneurysm was
indicated and performed in 13 patients (Fig. 1) with oper-
able CRC and median aneurysmal diameter of 6.5 cm
(range: 5.6e8.5 cm). In 10 patients, cancer resection was
performed initially, followed by EVAR in seven patients and
open aneurysm repair in three patients with juxtarenal
aneurysms. The median aneurysmal size was 6.1 cm (range:
5.5e7 cm), and interval to AAA repair was 8 months (range:
2e25 months).
Two patients with AAAs measuring 7 and 8 cm, respec-
tively, underwent aneurysm repair by EVAR prior to CRC
resection. The intervals to CRC resection were 2 and 1.5
months, respectively. Combined surgery was attempted in
one patient with an 8.5 cm suprarenal AAA and a descend-
ing colon carcinoma, but due to bleeding only the AAA was
repaired. Successful left hemicolectomy was undertaken 2
months later. In total, AAA was repaired by endovascular
technique in nine cases, and open surgery in four juxta- and
suprarenal aneurysms.
Seven patients underwent potentially curative resection
of their tumour alone. The median AAA size was 5.5 cm
(range: 4.0e7.5 cm). In four of these patients, elective AAA
repair was not indicated based upon aneurysmal diameter
(4.0, 4.3 and 5.2 cm infrarenal and 5.5 cm thoraco-
abdominal). One patient with a 5.8 cm infrarenal AAA is
having his aneurysm managed by best medical therapy and
surveillance. The vascular MDT made this decision basedThe management of concurrent colorecta
aneurismal disease.
AAA abdominal aortic aneurysm; CRC colore
repair.
Concurrent
disease
N=24
No surgery
indicated
N=4
One
procedure
indicated
N=7
Two
procedures
indicated
N=13
Palliati
AAA re
N=0
CRC re
N=7
AAA repair
Planned N
Actual N=3
CRC resec
first N=10
Joint proce
Planned N
Actual N=0
Figure 1 The management of concurrent colorectal malignanc
aneurysm; CRC colorectal cancer; EVAR endovascular aortic repairupon a high cardiovascular risk for open aneurysm-repair
surgery and anatomical unsuitability for EVAR. One patient
developed cancer recurrence post-resection; therefore,
repair of the 6.6 cm infrarenal AAA was not undertaken,
with non-aneurysm-related death at 16 months. The final
patient in this group had a complicated course post-CRC
surgery and was subsequently deemed unfit for repair of his
7.5 cm infrarenal aneurysm, followed by unrelated death at
6 months. At median follow-up of 12 months (range: 3e72
months), none of these aneurysms exhibited significant
dimensional changes. No patients had AAA repair per-
formed alone.
Table 1 provides the factors delaying the second
procedure in a staged plan, including chemoradiotherapy,
length of stay (LoS) and postoperative complications. One
patient with a 6.2 cm infrarenal AAA had adjuvant chemo-
radiotherapy between colonic surgery and EVAR. Post-
radiotherapy complications resulted in a time gap of 22
months, without interval aneurysmal rupture. There were
no other significant delays in receiving adjuvant treatment,
colorectal surgery or AAA repair.
Four patients with advanced malignancy (nZ 2) or
severe co-morbidities (nZ 2) received palliative care only.
In this group, the median AAA size was 5.9 cm (range: 3.5e
8.5 cm).
Length of Stay
The median LoS was 13 days (range: 4e63 days) following
CRC resection, 7 days following EVAR (range: 4e49 days)
and 12.5 days following open AAA repair (range: 7e14
days). The median total LoS was 20 days for CRC resection
followed by EVAR, 23 days for CRC resection followed by
open AAA repair, 35.5 days for EVAR followed by CRCl malignancy and aorto-iliac
ctal cancer; EVAR endovascular aortic
on
pair
section
 first
=2 (EVAR)
tion
AAA rupture
N=0
dure
=1
Proceed to open repair
N=3
Proceed to EVAR
N=7
AAA rupture
N=0
Graft Infection
N=0
y and aorto-iliac aneurismal disease. AAA abdominal aortic
.
Concurrent Colorectal Malignancy & Aortic Aneurysm 549resection and 23 days for open AAA repair followed by CRC
resection.
Morbidity and Mortality
With regards to EVAR, there were four cases of endoleak; of
these, two were type II e treated conservatively and shown
to have resolved on follow-up computed tomography (CT).
There were two cases of stent-graft occlusion, with both
requiring bypass.
Two patients had EVAR prior to CRC resection, one
having a prolonged admission of 49 days for a distal type I
endoleak with re-exploration and a complicated post-
operative course. Combined resection was planned in one
patient; however, bleeding during repair of the 8.5 cm
suprarenal aneurysm prevented proceeding to CRC resec-
tion, which was safely performed 2 months later. There was
no incidence of aortic graft sepsis in these three patients at
6, 16 and 17 months.
Ten of the 24 patients died at the median period of 16
months after the intervention (range: 2.5e74.5 months),
including three of the four patients undergoing palliative
care. Five of the seven patients who had CRC surgery alone
died: one was an in-hospital mortality following compli-
cated re-admission after anterior resection; two were due
to recurrence of Duke C stage cancer and two were unre-
lated deaths. A patient who had EVAR followed by cancer
resection died of unrelated causes at 2 years after the
procedure. Another patient who underwent resection of
Duke C CRC followed by EVAR died of metastatic recurrence
at 21 months.
Aortic Surveillance
All patients had regular CT surveillance following EVAR
(nZ 9). In patients who had staged surgery with CRC
resection initially (nZ 10, median AAA size 6.1 cm) or
colonic resection alone (nZ 7, median AAA size 5.5 cm),
there was no evidence of aneurysmal sac expansion or
complications on surveillance CT scans.
Review of the Literature
A summary of the published literature on the management
of concurrent colorectal malignancy and aorto-iliac aneu-
rysmal disease is seen in Table 2. Large series, describing
the management of greater than 10 cases, are outlined in
Table 3.
The literature review revealed 38 publications involving
269 cases of co-existing CRC and AAA. Of these, 101 were
treated by a combined approach. A staged approach was
taken in a further 142 cases, with the priority being CRC in
80 and AAA in 28 of these cases. In the remaining 34 cases of
staged management, the pathology treated first was not
declared. Importantly, in 18 cases, the use of EVAR was
described.
Mortality
Among the 269 cases, inpatient mortality rate was 4%
(nZ 11). A total of 18 (23%) mortalities, both early (within
30 days of intervention) and late, were recorded among the
80 patients who had CRC resection initially; six deaths (8%)were related to AAA. In cases where AAA repair was
undertaken first (nZ 28), there were seven mortalities
(25%), including one late death from aortic graft infection
(4%).3 Seven deaths were reported among the 101 patients
who had combined surgery (7%); of these, three were early
deaths (3%). Baxter et al. found that patients undergoing
open AAA repair followed by CRC resection (nZ 7) e
compared with combined surgery or staged with CRC
resection first e had the highest mortality rate (29%),
although this was not statistically significant.6
Morbidity
Interval Aortic Rupture in Staged Surgery
Hypotheses pertaining to interval AAA rupture include the
induction of matrix metalloproteinases, which degrade
extracellular matrix components in the aneurysm wall,
cytokine release and activation, impaired nutrition, factors
related directly to surgical dissection and steroid use and
chemotherapy.1,2,6,7,16e18,23 Of the 80 reports of staged
surgery where CRC was performed first, there were nine
(11%) interval AAA ruptures. Four (5%) were in the early
postoperative period (median size: 6.0 cm), and five (6%)
were late ruptures (median size: 6.3 cm). There was also
one late thrombosis of a 7.5 cm AAA (1%).2 Of these 10
complicated interval aneurysms, eight were 6 cm or larger
(10% complication rate), whilst two were less than 6 cm
(2.5% complication rate). There were no instances of
interval rupture in AAAs less than 5 cm in size.
Aortic Graft Infection
Aortic graft infection is one of the most feared complica-
tions. Although a number of authors expressed concern over
this potential risk with simultaneous surgery,14,15 in the
context of concurrent CRC and AAA the risk appears low.
Porcellini et al. reported a single mortality at 23 months
from sepsis due to aortic graft infection. This followed
a left hemicolectomy without anastomotic leak 15 days
after open AAA repair.3
CRC Morbidity
There were no documented cases of a CRC becoming non-
resectable (due to local or systemic progression) following
a delay in cancer treatment post-AAA repair. Baxter et al.
found a significant delay from CRC diagnosis to resection in
patients undergoing AAA repair performed first (median
delay: 122 days), compared with those undergoing CRC
resection first (median delays of 4 and 8 days, stratified by
AAA size) and those undergoing combined surgery (15 days)
(P< 0.0001).6 Clinical significance, such as stage migration
and cancer-specific outcome differences while awaiting
surgery, is not clear.
There were no published reports of sigmoid colon
ischaemia following right-sided CRC resection followed by
AAA repair. A total of six (2%) colonic anastomotic compli-
cations were reported e four (4%) with combined surgery,
one (4%) following staged surgery with AAA repair first and
one (1%) post staged intervention with CRC resection first.
EVAR in Concurrence
Five recent publications stated the importance and rec-
ommended the use of EVAR in concurrent AAA and CRC
Table 2 Summary of the review of the published literature on the management of concurrent colorectal malignancy and rto-iliac aneurysmal disease
Combined repair AAA repair first CRC resection first total
Number of cases 101 28 80 269
(including our series; not all
intervened upon); 142
staged approach
(priority of repair not declared
in all cases);
Mortality Early (30 days) AAA-related e e 2 (3%) 2 (0.7%)
Total 3 (3%) 2 (7%) 6 (8%) 11 (4%)
Late (>30 days) AAA-related e 1 AAA graft
infection (4%)
4 (5%) 5 (2%)
Total 4 (4%) 5 (18%) 12 (15%) 21 (8%)
Total AAA-related e 1 (4%) 6 (8%) 6 (2%)
Total 7 (7%) 7 (25%) 18 (23%) 32 (12%)
Complications Early
(30 days)
Interval AAA
rupture
e e 4 (5%) (>5, 6, 6, 6.4 AAA) 4 (2%)
Aortic graft
infection
e e e e
Colonic
anastomotic
4 (4%) 1 (4%) 1 (1%) 6 (2%)
Late
(>30 days)
Interval AAA
rupture
e e 5 (6%) (5, 6, 6.3, 9.5 cm AAA) 5 (2%)
Aortic graft
infection
e 1 (4%) e 1 (0.4%)
Total Interval AAA
rupture
e e 9 (11%) (note also 1
thrombosis of 7.5 cm A (1%)3)
9 (3%)
Aortic graft
infection
e 1 (4%)31 e 1 (0.4%)
Colonic
anastomotic
4 (4%) 1 (4%) 1 (1%) 5 (2%)
Total 4 (4%) 2 (7%) 10 (13%) 16 (6%)
AAA abdominal aortic aneurysm; CRC colorectal cancer; EVAR endovascular aortic repair.
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Table 3 Summary of major (greater than 10 cases) published series describing the management of concurrent colorectal malignancy and aorto-iliac aneurysmal disease
Article Ref. Total number
of cases
Number of combined repair Staged approach Conclusion
Total CRC repair first AAA repair first
Current study 17 1 (planned
but not completed)
5 5 (three AAA subsequently
repaired by EVAR)
1 (unplanned) See Discussion
Veraldi et al. 4 14 9 (EVAR not used) 4 0 4 (three EVAR) One-stage intervention
is preferred due to the lower
morbidity, avoiding a second
surgical and anaesthetic
insult. EVAR is a possible
solution to aid the one-stage
procedure.
Georgopoulos et al. 10 11 11 (two unspecified
complications)
0 0 0 One-stage approach
advocated as safe.
Matsumoto et al. 11 16 12 (no complications) 4 (not mentioned) (not mentioned) One-stage approach
is well tolerated
and can avoid
the time, financial
costs and patient
anxiety. EVAR not used
routinely in Japan
due to cost considerations.
Baxter et al. 6 83 12 71 Total 6444 with AAA
<5 cm20 with AAA
>5 cm(complicated by
two interval AAA ruptures)
7 (AAA >5 cm) Largest series
of patients.Comments:1. AAA
<5 cm: Resect CRC first,
followed by AAA surveillance.
2. AAA >5 cm: The authors
recognise the risk
of rupture vs. the delay
to treat CRC.3. Concomitant
treatment of both
may be beneficial,
especially in right-sided CRC.
Matsumoto et al. 12 14 7 (no operative
mortality or morbidity)
7 3 4 Use a one-stage
approach with AAA thrombo-
exclusion
with right-sided CRC or a
temporary
transverse colostomy for left-
sided CRC. APR can be done
simultaneously with AAA repair
via a transperitoneal approach.
(continued on next page)
C
o
n
cu
rre
n
t
C
o
lo
re
cta
l
M
a
lign
a
n
cy
&
A
o
rtic
A
n
e
u
rysm
551
Table 3 (continued )
Article Ref. Total number
of cases
Number of combined repair Staged approach Conclusion
Total CRC repair first AAA pair first
Robinson et al. 16 19 2 (1 postoperative
death)
5 5 (two interval AAA
ruptures, one leading
to the only perioperative
death)
1 ( AA rupture,
pat died intra-
ope ively)
Priority to CRC resection.
The authors recommend
that large (6 cm) AAAs should
either be given
preferential treatment or
resected
simultaneously, in view
of the high
risk of rupture.
Nora et al. 2 17 2 6 5 1 If the CRC is not symptomatic
and localised, AAA should
be resected first.
Longer-term survival
shown if both
lesions were treated,
as three late
deaths from complications
from unresected AAA in
patients
who had undergone
resection of CRC only.
AAA abdominal aortic aneurysm; CRC colorectal cancer; EVAR endovascular aortic repair.
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Concurrent Colorectal Malignancy & Aortic Aneurysm 553managements.3,4,6,8,24 Porcellini et al. compared EVAR
(nZ 4) and open AAA repair (nZ 5) in nine cases of
concurrent AAA and CRC. The EVAR group had shorter
median LoS (13.5 vs. 23 days), lower perioperative
complication rate (25% vs. 80%, including an aortic graft
infection) and perioperative mortality rate (0% vs. 20%).3 In
the endovascular group, a staged approach was taken with
EVAR sequenced first. In the open group, combined surgery
was performed in three cases, with CRC resection per-
formed first in one case and AAA repair first in the
remaining case. Kiskinis et al. describe an intentional delay
of 2 weeks for CRC resection following EVAR, thus allowing
shrinkage of the aneurysmal sac and facilitating
colectomy.8
Complications described when EVAR preceded CRC
resection include embolic occlusion of the popliteal
artery,25 three cases of endograft limb thrombosis after
rectal surgery in lithotomy position3,26 and one anastomotic
leak following anterior resection.3Discussion
The co-existence of abdominal malignancy and aorto-iliac
aneurysmal disease is uncommon, but may be increasing in
incidence with an ageing population as CRC and AAA
patients reside in the same age group and share other
demographic similarities. The management of these
concurrent pathologies continues to pose a therapeutic
dilemma, as evidenced by the disparity in published case
reports, series and recommendations. No prospective
randomised controlled trials or other level-one evidence
exist in order to form a standardised treatment algorithm or
facilitate the decision-making process. This is not surprising
given the numbers and heterogeneity in the group involved.
Most of the 38 publications reviewed offered clear
recommendations without clear evidence to support them.
Twenty papers promoted staged intervention; however,
not all specified priority of management. Nine recom-
mended treating life-threatening or symptomatic pathol-
ogies first. Eight suggested intervention of the AAA first if
the CRC was asymptomatic, with the reasons given for this
rationale including reduced risk of interval aneurysmal
complications with delayed AAA repair e with or without
adjuvant chemoradiotherapy e and more rapid recovery of
nutritional state. Only two groups recommended CRC
resection first if both pathologies were asymptomatic,
quoting low risk of interval aneurysmal rupture as their
justification.6,27 Eighteen articles promoted simultaneous
surgery for concurrent AAA and CRC, although one used
thrombo-exclusion in AAA management.12 Interestingly,
Baxter et al. recommend combined repair particularly in
right-sided CRCs,6 whilst Shimada et al. comment on its
safety and feasibility with left-sided CRC, particularly in
the context of a Hartmann’s procedure.9 The reasons
offered by publications for simultaneous surgery include:
it being successful in a number of series and reports; its
role in the unexpected finding of CRC during AAA
repair,13,28 simultaneous surgery reducing the time,
financial costs and anxiety of two separate operations;11
reduced morbidity4 and the facility to undertake concur-
rent surgery using EVAR.EVAR has revolutionised aneurysm-repair surgery with
benefits such as reduced hospital stay and short-term
survival and quality of life benefits.20,29 EVAR expands
management options in concurrence as it can form part of
a combined or staged approach. In a study analysing
outcomes following AAA repair in 13,902 patients, the
overall risk of aortic graft infection was 0.44%, without
a difference between EVAR and open repair.30 In the
context of concurrent pathology, EVAR is likely to lower the
risk of aortic graft infection as the endograft is inserted via
distal access sites into the intact aortic sac without
communication with the peritoneal cavity. The improved
recovery period with EVAR has the potential to reduce the
interval time to CRC resection and chemoradiotherapy and
reduce the systemic trauma of major surgery, which may
enhance tumour growth.31 As discussed, Porcellini et al.
demonstrated the benefit of EVAR over open repair in
concurrent disease in terms of LoS, morbidity and
mortality, undertaking EVAR prior to CRC resection.3
In the sub-population of patients deemed to be at high
risk, yet fit for operative intervention on their AAA, EVAR
should be considered as it has been shown to produce
outcomes superior to that of open repair.32 EVAR has
offered individuals unsuitable for open AAA repair,
including those with previous laparotomy and adhesions,
a therapeutic alternative.
In our series, the complication rate after EVAR is high
and may be explained by the presence of a concurrent
malignancy; for example, limb occlusions occurring due to
the thrombophilia of a paraneoplastic syndrome.
A potential disadvantage of a simultaneous approach
includes the theoretical increased risk of aortic graft
infection, carrying a mortality rate of 65%.33 This compli-
cation was not seen in our series and, although only a single
case was reported among 269 patients in the world litera-
ture, the risk of undertaking AAA repair and potentially
contaminating gastrointestinal surgery synchronously is
highlighted in a series of 14 infected aortic prostheses, two
being complications of concurrent abdominal surgery (gas-
trostomy and open cholecystectomy).34 With EVAR, groin
wound infection is the most likely source of endograft
infection. Although there are no published reports, the risk
of endograft infection secondary to the transient bacter-
aemia seen with CRC resection also necessitates consider-
ation,30 and perioperative antibiotic prophylaxis is
recommended.
Unrelated laparotomy is associated with risk of AAA
rupture in up to 16e24% of cases,16,18,23 and is particularly
true when aneurysmal diameter is greater than
5 cm.1,2,6,7,17,18 We favoured a staged approach in our
series and encountered no cases of interval aneurysmal
rupture, regardless of administration of adjuvant chemo-
radiotherapy. In the literature, delays in AAA repair due to
adjuvant chemoradiotherapy or complications following
colorectal surgery were not responsible for the observed
interval aneurysmal complications. Our review shows no
instances of interval rupture in AAAs less than 5 cm in size.
Although not requiring elective repair, preceding CRC
treatment has not caused significant expansion and rupture
in aneurysms sized less than 5 cm. Only two interval
complications occurred in AAAs less than 6 cm, with the
remaining eight in those greater than or equal to 6 cm
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Figure 2 Suggested management strategy in common scenarios in concurrent colorectal cancer and infrarenal abdominal aortic
aneurysm. This algorithm may be carefully employed in individuals in whom surgery is indicated for both their pathologies, and in
accordance with local practices and expertise. Combined intervention may include an open AAA repair and CRC resection, but may
involve open CRC resection with EVAR if aortic anatomy is amenable.
AAA abdominal aortic aneurysm; CRC colorectal cancer; EVAR endovascular aortic repair.
554 J. Shalhoub et al.(Table 2). Therefore, asymptomatic aneurysms less than
6 cm may have CRC treatment initially.
Our LoS following AAA repair is related to the significant
proportion of juxtarenal, suprarenal and thoraco-abdominal
aneurysms in this series, attributable to one of the centres
having a thoracic vascular programme. The presence of non-
infrarenal aneurysms was responsible for the necessity for
open AAA repair in a number of individuals. Currently,
fenestrated and branched stent-grafts are being introduced
in such cases. Patients considered unsuitable for conven-
tional infrarenal EVAR are likely to be at high risk by virtue of
such aneurysmal characteristics. Furthermore, it is the
policy at both centres to undertake inpatient CT, if serum
creatinine levels permit, at days 5e7 post-EVAR to rule out
endoleak requiring treatment prior to discharge. This fixes
in-hospital LoS for our EVAR patients to some extent.
Adjuvant oncological therapies are an additional factor
demanding consideration. Chemoradiotherapy, often
accompanied by corticosteroids and aggressive hydration
(expanding plasma volume), may result in enlargement and
rupture of major vessels including both aneurysmal35 and
non-aneurysmal36 aortas. Lauro et al. comment that
chemotherapy may increase rupture risk in AAAs larger than
6 cm in size, and suggest that such aneurysms be treated
first, as shown in a patient treated for pancreatic cancer.37
This may be due to inhibition of smooth muscle prolifera-
tion, and collagen and elastin productions. There are no
reports of chemoradiotherapy-induced aneurysmal rupture
in our review. In our series, one patient with a 6.5 cm AAA
had adjuvant chemotherapy deferred until after EVAR,whilst other patients with 6.9 and 7.0 cm AAAs had adju-
vant chemotherapy prior to EVAR without consequence. No
patients had palliative chemoradiotherapy withheld due to
concerns regarding AAA rupture.
Another risk inherent to staged surgery was the hostile
abdomen faced at second laparotomy. If EVAR is technically
feasible and CRC not urgently symptomatic, an approach
whereby EVAR is undertaken first could minimise the delay
to completion of surgical treatment of both conditions
without significantly delaying adjuvant therapies. A
counter-argument to this is if CRC resection is undertaken
as the primary procedure, this could enable more accurate
staging of the malignant disease and estimation of prog-
nosis, such that the decision to proceed to AAA repair can
be fully informed on this basis.
A suggested treatment algorithm for the common clin-
ical encounters is shown in Fig. 2, and this is to be carefully
applied. Where AAA repair is to be undertaken first as part
of a staged management plan, the use of EVAR with its
shorter recovery time may reduce the delay to treatment of
the CRC.21 EVAR should also be employed where possible in
individuals who are fit for surgery, but have high operative
risk owing to improved outcomes.32
Literature review revealed that published results
following staged and simultaneous surgery were similar;
therefore, combined intervention is an acceptable option,
both in the context of open AAA repair and EVAR. In the
case of obstructing CRC with an aneurysm 6 cm or larger in
size, where the risk of interval AAA rupture is significant,
both with and without adjuvant therapy,37 concurrent
Concurrent Colorectal Malignancy & Aortic Aneurysm 555intervention can be undertaken. Alternatively, the use of
temporary colonic stenting prior to AAA repair with subse-
quent CRC resection may be considered. This is preferred
to bowel de-functioning which may present a potential for
infection from the anterior abdominal wall when under-
taking open AAA repair or EVAR.
There is little reliable and validated evidence on this
area due to the considerable heterogeneity which exists
among the patients, as such a mutlispecialty, multidisci-
plinary approach remains essential in the formulation of
a safe and effective management strategy, tailored on an
individual basis. Most surgeons, however, agree that the
symptomatic or most life-threatening lesion should be
managed first. In this small observational series, following
colonic resection, no aneurysmal ruptures were observed
and as such staged management may be considered a safe
approach. Our review of the literature reveals a number of
such interval ruptures; hence, if this strategy is to be
employed, subsequent AAA repair should be planned and
undertaken as early as it is practical to do so. There is an
evolving role for EVAR in this context, with a shorter
recovery period and less pro-tumour effect.
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